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We thank Dr Mente and colleagues for their interest in our paper. We concur with their 
observation that our data further validates the use of a single urine collection method 
in large populations studies to estimate daily sodium intake based on the linear 
relationship observed between blood pressure and urinary sodium excretion1-3. In 
developing our original study we did explore the relationship between urinary sodium 
excretion and outcome using restricted cubic splines, but elected to present 
categorized data for clarity.  Here we present restricted cubic splines, fully adjusted 
for all variables as per the original analyses. As per our original manuscript, we present 
data on 322,624 subjects without baseline cardiovascular disease, diabetes or 
hypertension. Over a median follow-up time of 6.99 years (IQR 6.29-7.64 years) there 
were 6742 deaths, 3016 of which were in women (44.7%).  There were 740 fatal CVD 
events in men and 364 in women, and 6972 nonfatal CVD events in men and 3739 in 
women. There remains no clear relationship between increasing sodium excretion and 
adverse outcomes (Figure 1). At the lower end of sodium excretion, there is a 
suggestion of poorer outcomes with lowest sodium excretion below 3g (Figure 1A and 
1C, as suggested by Mente), but this is no longer significant after controlling for 
reverse causality by excluding subjects with a Charlson comorbidity index greater than 
zero (as per our original paper) (Figure 1B and 1D). In summary, we agree that there 
is indeed a disassociation between increased sodium intake and adverse outcome in 
patients at low cardiovascular risk. However, our analyses of UK biobank data suggest 
the observation between sodium intake <3g and adverse outcomes, reported by other 
studies is at least partially driven by reverse causality4. Only a randomised clinical trial 
of differing sodium intake would address this issue. We accept that such a study would 
be challenging to undertake. 
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Figure Legend 
Figure 1 
Fully adjusted cubic spline of hazard ratio (HR) for cardiovascular disease (CVD; top 
panels A and B) or all cause mortality (ACM; bottom panels C and D) across the range 
of estimated 24h urinary sodium excretion in UK Biobank subjects free of 
cardiovascular disease, diabetes mellitus or hypertension at baseline.  Right panels 
(B and D) present sensitivity analyses restricted to subjects with Charlson comorbidity 
score of zero. 
 
 
 
 
